Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer
Abstract Immune checkpoint inhibitors (ICIs) have demonstrated efficacy in advanced esophageal squamous cell carcinoma (ESCC). Heterogeneous responses to ICIs have been reported previously. Here, we describe a patient with advanced ESCC exhibiting a response to durvalumab plus tremelimumab for more...
Main Authors: | Jhe‐Cyuan Guo, Chia‐Lang Hsu, Min‐Shu Hsieh, Chia‐Chi Lin, Ta‐Chen Huang, Hung‐Yang Kuo, Yu‐Yun Shao, Chih‐Hung Hsu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14997 |
Similar Items
-
Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma
by: Patrizia Gasparini, et al.
Published: (2019-09-01) -
Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer
by: Sara Kaczor Elbæk, et al.
Published: (2023-12-01) -
Research progress of immune contexture in tumorigenesis, progression and prognostic relevance of non-small cell lung cancer
by: SHEN Yujia , FU Xiaolong
Published: (2021-11-01) -
Research Progress of Predictive Markers for Efficacy of Immune Checkpoint Inhibitors for Esophageal Squamous Cell Carcinoma
by: CHEN Rongshan, et al.
Published: (2022-12-01) -
Immune checkpoint inhibitors combined with concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
by: Jiang-Qiong Huang, et al.
Published: (2024-03-01)